Association between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death among Patients with Immune-Mediated Inflammatory Disease and COVID-19 | Zendy

Z. Izadi | Zendy; E.J. Brenner | Zendy; Satveer Mahil | Zendy; N. Dand | Zendy; Z.Z.N. Yiu | Zendy; M. Yates | Zendy; R.C. Ungaro | Zendy; X. Zhang | Zendy; Manindra Agrawal | Zendy; J.-F. Colombel | Zendy; M.A. Gianfrancesco | Zendy; K.L. Hyrich | Zendy; A. Strangfeld | Zendy; L. Carmona | Zendy; E.F. Mateus | Zendy; S. Lawson-Tovey | Zendy; E. Klingberg | Zendy; G. Cuomo | Zendy; M. Caprioli | Zendy; A.R. Cruz-Machado | Zendy; A.C. Mazeda Pereira | Zendy; R. Hasseli | Zendy; A. Pfeil | Zendy; H.-M. Lorenz | Zendy; B.F. Hoyer | Zendy; L. Trupin | Zendy; Sloan Rush | Zendy; PAUL KATZ | Zendy; G. Schmajuk | Zendy; L. Jacobsohn | Zendy; A.M. Seet | Zendy; S. Al Emadi | Zendy; L. Wise | Zendy; E.L. Gilbert | Zendy; A. Duarte-García | Zendy; M.O. Valenzuela-Almada | Zendy; C.A. Isnardi | Zendy; R. Quintana | Zendy; E.R. Soriano | Zendy; T.Y.-T. Hsu | Zendy; K.M. D apos Silva | Zendy; J.A. Sparks | Zendy; N.J. Patel | Zendy; R.M. Xavier | Zendy; C.D.L. Marques | Zendy; A.M. Kakehasi | Zendy; R.-M. Flipo | Zendy; P. Claudepierre | Zendy; A. Cantagrel | Zendy; P. Goupille | Zendy; Z.S. Wallace | Zendy; S. Bhana | Zendy; W. Costello | Zendy; R. Grainger | Zendy; J.S. Hausmann | Zendy; J.W. Liew | Zendy; E. Sirotich | Zendy; P. Sufka | Zendy; P.C. Robinson | Zendy; P.M. Machado | Zendy; C.E.M. Griffiths | Zendy; J.N. Barker | Zendy; C.H. Smith | Zendy; J. Yazdany | Zendy; M.D. Kappelman | Zendy

Open Access

Association between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death among Patients with Immune-Mediated Inflammatory Disease and COVID-19

Author(s) -

Z. Izadi,

E.J. Brenner,

Satveer Mahil,

N. Dand,

Z.Z.N. Yiu,

M. Yates,

R.C. Ungaro,

X. Zhang,

Manindra Agrawal,

J.-F. Colombel,

M.A. Gianfrancesco,

K.L. Hyrich,

A. Strangfeld,

L. Carmona,

E.F. Mateus,

S. Lawson-Tovey,

E. Klingberg,

G. Cuomo,

M. Caprioli,

A.R. Cruz-Machado,

A.C. Mazeda Pereira,

R. Hasseli,

A. Pfeil,

H.-M. Lorenz,

B.F. Hoyer,

L. Trupin,

Sloan Rush,

PAUL KATZ,

G. Schmajuk,

L. Jacobsohn,

A.M. Seet,

S. Al Emadi,

L. Wise,

E.L. Gilbert,

A. Duarte-García,

M.O. Valenzuela-Almada,

C.A. Isnardi,

R. Quintana,

E.R. Soriano,

T.Y.-T. Hsu,

K.M. D apos Silva,

J.A. Sparks,

N.J. Patel,

R.M. Xavier,

C.D.L. Marques,

A.M. Kakehasi,

R.-M. Flipo,

P. Claudepierre,

A. Cantagrel,

P. Goupille,

Z.S. Wallace,

S. Bhana,

W. Costello,

R. Grainger,

J.S. Hausmann,

J.W. Liew,

E. Sirotich,

P. Sufka,

P.C. Robinson,

P.M. Machado,

C.E.M. Griffiths,

J.N. Barker,

C.H. Smith,

J. Yazdany,

M.D. Kappelman

Publication year - 2021

Publication title -

carolina digital repository (university of north carolina at chapel hill)

Language(s) - English

DOI - 10.17615/2fq5-qd62

Subject(s) - tumor necrosis factor alpha , immune system , disease , covid-19 , medicine , tumor necrosis factor α , association (psychology) , immunology , necrosis , risk factor , infectious disease (medical specialty) , psychology , psychotherapist

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research